What stage does Oncology Ventures invest at?

Oncology Ventures invests at the Seed, Series A, Series B stages.

Where is Oncology Ventures located?

Oncology Ventures is headquartered in New York, US.

Oncology Ventures

Venture capitalActively deploying

New York · Seed–Series B · 18 people tracked

Also known as ONCOLOGY VENTURES LLC

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Oncology Ventures invests in healthcare data companies addressing the biggest challenges in cancer care. The firm views the U.S. oncology system as fragmented, expensive, and full of barriers to evidence-based care. It funds data-driven technologies spanning early detection, precision diagnostics, patient navigation, survivorship, AI-powered treatment optimization, and the non-drug infrastructure that makes treatment effective in the real world. The goal is to reduce avoidable cancer deaths by improving early detection, ensuring guideline-based care for every patient, and building infrastructure that turns existing medical knowledge into lives saved.

Invests inAI & Machine Learning Biotech Data & Infrastructure Digital Health Healthtech Medical DevicesBoca RatonNew YorkUnited States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series B

New York, New York, US

Instruments

Equity

Founded

2018

AUM

$30M

VC funds

Tracked investments

Team · 18 people

from the firm's website

Ben Freeberg· Founder, Managing Partner· Austin, Texas, United Statesin

Founder of Oncology Ventures. A testicular cancer survivor diagnosed in 2018, his firsthand experience with the fragmented cancer care system motivated him to start the firm to back founders building the future of cancer care.

b•••@oncology.venturesreveal

Brad Hively· Advisor· Los Angeles, California, United Statesin

Former CEO and current Vice Chairman of The Oncology Institute (NASDAQ: TOI), which he led through its 2021 public listing. Previously a healthcare investor at TA Associates, General Atlantic, and RLH Equity.

Carolyn Starrett· Advisor· San Francisco Bay Areain

CEO of Flatiron Health, leading efforts to turn real-world patient data into cancer research insights. Former principal at Boston Consulting Group; holds an MBA from Kellogg.

David Cohn· Interim Chief Executive Officer and Chief Medical Officer· Columbus, Ohio, United Statesin

Physician and gynecologic oncologist leading a cancer hospital's strategic direction. An NCI-funded scientist with 300+ published manuscripts. Member of the Limited Partner Advisory Committee.

Diana Verrilli· General Manager, Navista (a Cardinal Health company)· Denver Metropolitan Areain

Healthcare executive focused on community oncology, with two decades at McKesson and The US Oncology Network and a prior role as Chief Growth Officer at DispatchHealth. Member of the Limited Partner Advisory Committee.

Emily Melton· Advisor· San Francisco Bay Areain 𝕏

Investor at Threshold who backed Redfin in 2007 after following the company, drawn to its vision and founding team; evaluates founders by their resilience and drive.

e•••@threshold.vcreveal

Harlan Levine· President of Health Innovation and Policy, City of Hope· Los Angeles County, California, United Statesin

Leads innovation and government relations at City of Hope and chairs the board of AccessHope. Previously held executive roles at UnitedHealth Group, Towers Watson, and Anthem. Member of the Limited Partner Advisory Committee.

Jason Shook· Chief Operating Officer, Texas Oncology· Dallas-Fort Worth Metroplexin

COO of Texas Oncology and former CFO of The US Oncology Network and McKesson's practice management business. Member of the Limited Partner Advisory Committee.

Jay Freeberg· Chief Financial Officer· Boca Raton, Florida, United Statesin

CFO and CPA/CFP, partner emeritus of a New York accounting firm and long-time financial planner operating through Onyx Bridge Wealth Group.

Jennifer Malin· Advisor· Los Angeles Metropolitan Areain

Physician who served as CMO of Optum Health Solutions and led value-based oncology programs at UnitedHealthcare, with expertise in reimbursement and alternative payment models.

Jenny Soriano· Manager, Venture Studio at Atlantic Health· New York City Metropolitan Areain

Manages the Venture Studio at Atlantic Health, leading innovation through partnerships, investments, and venture development. Member of the Limited Partner Advisory Committee.

Karen Knudsen· Advisor· Wynnewood, Pennsylvania, United Statesin

CEO of the Parker Institute for Cancer Immunotherapy and former CEO of the American Cancer Society. Serves on the boards of AstraZeneca and several biotech companies.

Khail Macadaeg· Executive Assistant· Quezon City, National Capital Region, Philippinesin

Executive assistant with 15+ years of experience across healthcare, technology, public policy, and research, focused on operations and executive support. Pursuing an MBA and holds a bachelor's in Anthropology from the University of the Philippines.

Lee Newcomer· Advisor· Minnetonka, Minnesota, United Statesin

Physician who served as Chief Medical Officer of UnitedHealth Group and pioneered value-based oncology payment models. Serves as a director at Myriad Genetics, Coherus Bioscience, and Cellworks.

Nancy Brown· Advisor· New York, New York, United Statesin 𝕏

General Partner at Oak HC/FT focused on healthcare growth and early-stage investing, with prior executive roles at McKesson, athenahealth, and Harvard Community Health Plan.

n•••@oakhcft.comreveal

Nandita Kotwani· Venture Associate· New York, New York, United Statesin

Venture associate with oncology strategy and operations experience, having worked at Memorial Sloan Kettering, Flatiron Health, and City of Hope. Holds a Master of Health Administration from Columbia University.

n•••@oncology.venturesreveal

Nida Shekhani· Deputy COO & Chief Strategy Officer, Fred Hutch· Greater Seattle Areain

Deputy COO and Chief Strategy Officer at Fred Hutch, overseeing business development and strategic planning, with prior roles at UChicago Medicine, UCSF Health, and New York-Presbyterian. Member of the Limited Partner Advisory Committee.

Xavier Avat· Chief Business Officer, Moffitt Cancer Center· Tampa, Florida, United Statesin

Leads business development and innovation strategy at Moffitt Cancer Center, with nearly 30 years of experience including roles at Capricor Therapeutics, Genentech, and Gilead Sciences. Member of the Limited Partner Advisory Committee.

What they invest in

from 10 of 28 portfolio companies

Healthtech ×10Digital Health ×4AI & Machine Learning ×3Biotech ×3Medical Devices ×3SaaS ×2Data & Infrastructure ×1Enterprise Software ×1

HQs:United States×9

Investments · 28 tracked

founders shown can be your intro path

BIOMAKERSbiomakers.netin

Biomakers builds precision genomic data infrastructure for oncology drug and diagnostic development, focusing on Latin America's underrepresented genetic diversity.

BiotechData & InfrastructureHealthtechCity Of Dover, County Of Kent, US

Ruben Javier Salanova(Director)Pablo Fernandez(Director)Juan Manuel Marrone(Secretary)Consuelo Valverde(Director)Clarisa Diana Lifsic(Director, Treasurer)Nicolas Kirchuk(Director, Chief Executive Officer, President)

PartnerBen Freeberg· solo GP

Cancernavigatorcancernavigator.comin

CancerNavigator provides oncology nurse navigation and patient support services, helping cancer patients and their families access care and resources throughout treatment.

Digital HealthHealthtechWellness & FitnessWashington, US

Adam J Bradley(Executive Officer, Director)Shelley Zhuang(Director)Spencer Brittain Bradley(Executive Officer, Director)Spencer Bradley(Co-founder)Adam Bradley(Co-founder & CEO)Philip Aiken(President)

PartnerBen Freeberg· solo GP

Daymark Healthdaymarkhealth.comin

HealthtechPhiladelphia, US

Paul Dufault(Executive Officer)Kelsey Maguire(Director)Ambar Bhattacharyya(Director)Roy Beveridge(Director)Aman Mahajan(Director)Justin Bekelman(Executive Officer, Director)

PartnerBen Freeberg· solo GP

FidoCure®fidocure.comin 𝕏

One Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Christina Lopes(Founder)inBen Lewis(Co-founder)

PartnerBen Freeberg· solo GP

Gabbigabbi.comin 𝕏

Gabbi provides clinically-validated online breast cancer risk assessment and expert virtual care coordination for women through health systems, employers, and providers.

Digital HealthFemTechHealthtechPortland, US

Kaitlin Christine(Founder and CEO)

PartnerBen Freeberg· solo GP

Health Universehealthuniverse.comin 𝕏

PartnerBen Freeberg· solo GP

Ignite

Saves research coordinators time and reduces lab queries in clinical research.

PartnerBen Freeberg· solo GP

IgniteDataignitedata.comin

PartnerBen Freeberg· solo GP

Kadancekadance.comin

PartnerBen Freeberg· solo GP

Lumonous

PartnerBen Freeberg· solo GP

Lumonuslumonus.comin 𝕏

HealthtechNorth Sydney

Sarah Butler(Director)Merrick Howes(Executive Officer, Director)Rebecca Edwards(Executive Officer)Nicholas Todhunter(Director)Keith Hansen(Executive Officer, Director)Wally Curran(Director)

PartnerBen Freeberg· solo GP

Modicus Primemodicusprime.comin

Modicus Prime provides an AI Management System (AIMS) for pharmaceutical companies and contract development and manufacturing organizations (CDMOs) to validate, audit, and govern AI systems across their operations in compliance with FDA and other regulatory requirements.

AI & Machine LearningBiotechHealthtechSaaSLa Porte, US

Taylor Chartier(Founder & CEO)Davit Vardanyan(Director)

BoardRoger Chen(Director)

PartnerBen Freeberg· solo GP

mPATH

Improves patient access to cancer screening regardless of location, addressing missed lung cancer screenings.

PartnerBen Freeberg· solo GP

mPATH Healthmpathhealth.com

PartnerBen Freeberg· solo GP

Nexcurenexcure.com

PartnerBen Freeberg· solo GP

OncoveryCare

Virtual-first cancer survivorship care model for post-treatment patients.

PartnerBen Freeberg· solo GP

Precision medicineconcr.coin

PartnerBen Freeberg· solo GP

Reimagine Carereimaginecare.comin

PartnerBen Freeberg· solo GP

RISA

Automates workflows at cancer centers, freeing staff time and generating system savings.

PartnerBen Freeberg· solo GP

Risa Labsrisalabs.aiin

PartnerBen Freeberg· solo GP

Spotdocspotdoc.com

PartnerBen Freeberg· solo GP

Stitch Healthstitchhealth.coin

PartnerBen Freeberg· solo GP

Tono

Helps patients receive advanced specialty care and stay on treatment by managing side effects.

PartnerBen Freeberg· solo GP

Toño

PartnerBen Freeberg· solo GP

Tonohealthtonohealth.com

PartnerBen Freeberg· solo GP

Triomicstriomics.comin 𝕏

Triomics builds AI systems for oncology teams that read full patient records and produce structured, auditable outputs for trial matching, visit preparation, and data curation.

AI & Machine LearningHealthtechMedical DevicesNew York City, US

Sarim Khan(Founder)inHrituraj Singh(Founder)inDevtosh Kumar Khare(Director)Sameer Brij Verma(Director)Sajjan Rajpurohit(Director)

PartnerBen Freeberg· solo GP

VivorCareoncoverycare.comin 𝕏

OncoveryCare develops survivorship care solutions for cancer survivors, addressing the medical and quality-of-life needs of people living after cancer treatment.

Digital HealthHealthtechMedical DevicesBoston, US

PartnerBen Freeberg· solo GP

well beamwell-beam.com

WellBeam provides an EMR-integrated platform that connects acute and post-acute care providers, enabling physicians to authorize orders and respond to clinical concerns across the care continuum.

Enterprise SoftwareHealthtechSaaSPalo Alto, US

James Huie(Executive Officer)Amee Devani(Executive Officer, Director)Jon Lim(Director)

PartnerBen Freeberg· solo GP

Frequently asked questions

What stage does Oncology Ventures invest at?: Oncology Ventures invests at the Seed, Series A, Series B stages.
What sectors does Oncology Ventures focus on?: Oncology Ventures focuses on AI & Machine Learning, Biotech, Data & Infrastructure, Digital Health, Healthtech, Medical Devices.
Where is Oncology Ventures located?: Oncology Ventures is headquartered in New York, US.

Media · Podcasts & interviews

featuring the team

Funded: The VC Who Invests in Cancer Care From the Inside | Ben Freeberg, Oncology Ventures

airCFO for Startups · Ben Freeberg

REPLAY - Raising a $30M Fund 1 to Combat Cancer with Ben Freeberg of Oncology Ventures

Money Moves · Ben Freeberg

Similar investors

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

Capricorn Venture Partners

Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.

$270K – $10.8M

DCVC (Data Collective)

DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.

$5M – $25M

GV (Google Ventures)

GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.